Recent advancements and future submissions of silica core-shell nanoparticles

Int J Pharm. 2021 Nov 20:609:121173. doi: 10.1016/j.ijpharm.2021.121173. Epub 2021 Oct 8.

Abstract

The core-shell silica-based nanoparticles (CSNPs) possess outstanding properties for developing next-generation therapeutics. CSNPs provide greater surface area owing to their mesoporous structure, which offers a high opportunity for surface modification. This review highlights the potential of core-shell silica-based nanoparticle (CSNP) based injectable nanotherapeutics (INT); its role in drug delivery, biomedical imaging, light-triggered phototherapy, Plasmonic enhancers, gene delivery, magnetic hyperthermia, immunotherapy, and potential as next-generation theragnostic. Specifically, the conceptual crosstalk on modern synthetic strategies, biodistribution profiles with a mechanistic view on the therapeutics loading and release modeling are dealt in detail. The manuscript also converses the challenges associated with CSNPs, regulatory hurdles, and their current market position.

Keywords: Bioimaging; Core-shell nanoparticles; Injectable nanotherapeutics; Phototherapy; Silica core.

Publication types

  • Review

MeSH terms

  • Drug Delivery Systems
  • Hyperthermia, Induced*
  • Nanoparticles*
  • Silicon Dioxide
  • Tissue Distribution

Substances

  • Silicon Dioxide